Wie sind die Öffnungszeiten?

Montag 09:00 - 17:00 Dienstag 09:00 - 17:00 Mittwoch 09:00 - 17:00 Donnerstag 09:00 - 17:00 Freitag 09:00 - 17:00

Nanolive

Name: Nanolive
Address: Route de Lully 5B, Lully, 1131, CH
Telephone: +41213530600

: Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics.

Nanolive delivers breakthrough 3D imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. Nanolive’s innovative solutions combine screening, imaging and analysis to radically advance how scientists study living cells and provide novel biological insights such as the mechanisms of cancer and neurodegenerative diseases.

06/05/2026

𝗧𝗼𝗱𝗮𝘆'𝘀 𝗲𝘃𝗲𝗻𝘁: 𝗢𝗻𝗲 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝗳𝗼𝗿 𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁
Discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies.

➡️ Register for the Online walkthrough below!
https://bit.ly/4ncMl7R

04/05/2026

𝗟𝗶𝘃𝗲 𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗱𝗮𝘁𝗮 𝘄𝗮𝗹𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵
Join us online on May 6th to discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies. Using real data we will show how to reduce time, costs and errors, by simplifying fragmented assays into a single process to accelerate screening and selection of therapies.

Register now: https://bit.ly/4tYqXpP

From activation to target engagement and killing, Nanolive’s revolutionary technology enables the identification of the most effective therapeutic candidates using live, label-free and automated analysis of effector cell activation, interactions, and killing. This session will present insights from nonadherent AML and CML models with gamma-delta T cells, and human CAR T cells, using the only high-resolution and automated system for quantifying the effector cell response in co-culture.

Stop screening immunotherapies with fragmented assays.

Understand activation, engagement, and killing dynamics in one experiment.

This video shows AI-classification of T cell activation state: T cells with an active morphology are colored cyan, dead T cells are colored brown, and inactive T cells are colored blue.

01/05/2026

𝗗𝗼𝗲𝘀 𝗧 𝗰𝗲𝗹𝗹-𝘁𝗮𝗿𝗴𝗲𝘁 𝗶𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝗼𝗻 𝗴𝘂𝗮𝗿𝗮𝗻𝘁𝗲𝗲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗸𝗶𝗹𝗹𝗶𝗻𝗴?
Understanding the balance between T cell killing, persistence, and exhaustion is the essential basis for creating effective CAR T cell therapies for cancer and auto-immune conditions. How can heterogeneous T cell responses be studied, and how can CAR T cells be enhanced for improved persistence and efficacy?

Join us online on May 6th to discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies.

Register now: https://bit.ly/3R9pqhN

This video shows four pancreatic cancer cells that are mostly static with smaller T cells crawling and moving very quickly trying to find cancer cells to kill them. Despite the best efforts of the T cells the cancer cells evade them by not being recognized.

27/04/2026

𝗛𝗼𝘄 𝗰𝗮𝗻 𝘄𝗲 𝗮𝘀𝘀𝗲𝘀𝘀 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗵𝗮𝗿𝗺𝗳𝘂𝗹 𝗹𝗮𝗯𝗲𝗹𝘀?
Most conventional methods rely on endpoint measurements or destructive sample preparation, which limits the ability to dynamically monitor and quantify effector cell behavior over time.

The LIVE T Cell Assay offers a powerful alternative: continuous, label-free monitoring of effector engagement, killing, and target cell response, all in real time and without stains or dyes. The assay can be seamlessly integrated into your immunotherapy development workflows to support candidate selection, functional validation, and potency testing.
Join us online on May 6th to discover how Nanolive’s non-invasive, AI-powered solution provides dynamic functional readouts and enables scientists to evaluate killing efficiency, optimize CAR-T cell selection, and gain deeper mechanistic insights.

Register now: https://bit.ly/4vNhUcu

In this video, two populations of leukemia cells with T cells are shown side-by-side and cancer cell death is captured in real-time following CAR-T cells' engagement. The leukemia cells have been automatically segmented and classified as living (green) or dead (brown) revealing successful killing by T cells in the left well.

24/04/2026

𝗟𝗮𝗯𝗲𝗹-𝗳𝗿𝗲𝗲 𝗧 𝗰𝗲𝗹𝗹 𝗲𝗳𝗳𝗶𝗰𝗮𝗰𝘆 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁
Early-stage research and development still lack tools that can accurately and dynamically assess immune cell function and potency. Existing technologies such as flow cytometry and fluorescence-based imaging often rely on endpoint measurements and fluorescent labelling, limiting real-time functional insights and introducing bias from phototoxicity. To address these limitations, Nanolive’s label-free technology offers an end-to-end solution for studying therapeutic efficacy and potency of effector cells in real-time.

Join us online on May 6th to discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies.

Register now: https://bit.ly/4cmj5rI

22/04/2026

𝗟𝗶𝗾𝘂𝗶𝗱 𝘁𝘂𝗺𝗼𝗿 𝗺𝗼𝗱𝗲𝗹𝘀- 𝘆𝗼𝘂 𝗮𝘀𝗸𝗲𝗱, 𝘄𝗲 𝗮𝗻𝘀𝘄𝗲𝗿𝗲𝗱
See for yourself how Nanolive’s AI-powered solution for live cell analysis is leading the field in non-invasive cell therapy screening! In this online session presenting insights from nonadherent AML and CML models in co-culture with gamma-delta T cells, and human CAR T cells, we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies.

Stop screening immunotherapies with fragmented assays.

Understand activation, engagement, and killing dynamics in one experiment.

Sign up for our online data walkthrough on May 6th: https://bit.ly/41Lq0oc

21/04/2026

𝗢𝗻𝗹𝗶𝗻𝗲 𝗱𝗮𝘁𝗮 𝘄𝗮𝗹𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵: 𝗢𝗻𝗲 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝗳𝗼𝗿 𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁
Discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies. Using real data, we show how to reduce time, costs and errors, by simplifying fragmented assays into a single process to accelerate screening and selection of therapies.

From activation to target engagement and killing, Nanolive’s revolutionary technology enables the identification of the most effective therapeutic candidates using live, label-free and automated analysis of effector cell activation, interactions, and killing. This session will present insights from nonadherent AML and CML models with gamma-delta T cells, and human CAR T cells, using the only high-resolution and automated system for quantifying the effector cell response in co-culture.

Stop screening immunotherapies with fragmented assays.

Understand activation, engagement, and killing dynamics in one experiment.

Sign up here: https://bit.ly/4tHA8uF

20/04/2026

𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝗽𝗿𝗲𝘀𝗲𝗻𝘁: 𝗖𝗮𝗻𝗰𝗲𝗿 𝗰𝗲𝗹𝗹 𝗱𝗲𝗮𝘁𝗵 𝗮𝗻𝗱 𝗶𝗺𝗺𝘂𝗻𝗲 𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴
Join scientists from MIT, Mass General Hospital and Harvard Medical School as they share their research into immune cell engineering and ferroptosis in cancer cells. In this seminar co-hosted by Nanolive and the Nanowell Cytometry Platform MIT Koch Institute for Integrative Cancer Research, explore real-world applications in cancer cell death and immune engineering, featuring Nanolive’s label-free live cell imaging.

𝙀𝙣𝙜𝙞𝙣𝙚𝙚𝙧𝙞𝙣𝙜 𝙄𝙢𝙢𝙪𝙣𝙚 𝘾𝙚𝙡𝙡𝙨 𝙩𝙤 𝙊𝙫𝙚𝙧𝙘𝙤𝙢𝙚 𝙩𝙝𝙚 𝘾𝙖𝙣𝙘𝙚𝙧 𝘾𝙚𝙡𝙡 𝙂𝙡𝙮𝙘𝙤𝙘𝙖𝙡𝙮𝙭
Sangwoo Park, PhD - Instructor, Mass General Hospital & Harvard Medical School

𝘼 𝙉𝙚𝙬 𝙒𝙞𝙣𝙙𝙤𝙬 𝙞𝙣𝙩𝙤 𝙁𝙚𝙧𝙧𝙤𝙥𝙩𝙤𝙨𝙞𝙨: 𝙇𝙖𝙗𝙚𝙡-𝙁𝙧𝙚𝙚 𝙄𝙢𝙖𝙜𝙞𝙣𝙜 𝙤𝙛 𝘾𝙚𝙡𝙡𝙪𝙡𝙖𝙧 𝘿𝙚𝙖𝙩𝙝
Ryan Mansell - Graduate Student, Koch Institute for Integrative Cancer Research, MIT

First hosted on April 9th, you can now catch up online: https://bit.ly/3OhgDJT

16/04/2026

𝗪𝗲'𝗿𝗲 𝗵𝗶𝗿𝗶𝗻𝗴: 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗖𝗼𝗼𝗿𝗱𝗶𝗻𝗮𝘁𝗼𝗿 (𝗦𝘄𝗶𝘁𝘇𝗲𝗿𝗹𝗮𝗻𝗱)
Are you the kind of person who thrives bringing structure and clarity to a fast-moving environment? We are looking for a driven and detail-oriented Commercial Operations Coordinator to join our growing team. You will play a key role in supporting the commercial function by streamlining processes, coordinating cross-functional activities, and ensuring the smooth ex*****on of our sales operations.

For more details about the role, please visit https://bit.ly/3OtCfCO

Nanolive is transforming live-cell imaging with cutting-edge technology that seamlessly combines screening, imaging, and AI-powered analysis. Our solutions empower researchers to accelerate discoveries in drug development, cell therapy, and beyond.

💡 If you’re excited by the idea of merging deep tech with life sciences to make real-world impact, we’d love to meet you!

15/04/2026

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗲𝗺𝗯𝗿𝘆𝗼 𝗺𝗼𝗱𝗲𝗹𝘀: 𝗽𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗮𝗹𝗲𝗿𝘁!
A new publication in Nature Cell Research uses Nanolive's continuous live cell imaging to capture stem cell differentiation dynamics in 3D. By imaging horizontal slices at the apex and base of cells, researchers were able to determine how microlumens formed between cells, and by imaging continuously for hours the dynamics of microlumen formation and development could be followed.

This work will help to broaden our understanding of embryogenesis and blastocyst development- congratulations to all the authors involved!

Read the full paper here (open access): https://www.nature.com/articles/s41422-026-01239-3

To learn more about Nanolive's label-free technology and its unique advantages in comparison to other imaging methods, download our eBook here:
https://bit.ly/47XkQck

This video (Supplementary video 5) shows Nanolive's RI-based 3D holotomography with lysosomes fluorescently tagged in red. Scale bar 20 μm.
Used under Creative Commons Licence CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/)

13/04/2026

🔬 𝗥𝗲𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝗵𝗶𝗴𝗵-𝗰𝗼𝗻𝘁𝗲𝗻𝘁 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗹𝗮𝗯𝗲𝗹-𝗳𝗿𝗲𝗲, 𝗱𝘆𝗻𝗮𝗺𝗶𝗰 𝗰𝗲𝗹𝗹 𝗽𝗮𝗶𝗻𝘁𝗶𝗻𝗴
How can we capture complex drug effects without fluorescent labels? In this poster, we showcase a comprehensive, label free approach to high content screening; combining advanced imaging with AI powered analysis to simultaneously assess drug effects at both the population and organelle levels.

Presented last week at the MitOX conference, discover how this method enables deep phenotypic profiling and mechanism of action insights, without the need for fluorescent staining.

👉 Download the poster to explore how label free imaging is transforming phenotypic screening.

https://bit.ly/4sobvBr

Adresse

Route De Lully 5B
Lully
1131

Öffnungszeiten

Montag	09:00 - 17:00
Dienstag	09:00 - 17:00
Mittwoch	09:00 - 17:00
Donnerstag	09:00 - 17:00
Freitag	09:00 - 17:00

Telefon

+41213530600

Webseite

http://nanolive.ch/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Nanolive erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.